MedPath
NMPA Approval

Neostigmine Methylsulfate Injection

国药准字H20249320

November 15, 2024

Drug Information

甲硫酸新斯的明注射液

注射剂

2ml∶1mg

化学药品

November 15, 2024

Company Information

Applicant Company

山西省大同市经济技术开发区第一医药园区

Manufacturing Company

山西省大同市经济技术开发区第一医药园区

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.